论文部分内容阅读
目的：研究酪酸杆菌双歧杆菌二联活菌联合马来酸曲美布汀治疗急性胃肠炎的临床效果。方法：抽取2012年8月至2014年9月在我科进行治疗的108例急性胃肠炎患者，随机分成观察组和对照组，各54例，对照组采取酪酸杆菌双歧杆菌二联活菌治疗，观察组采取酪酸杆菌双歧杆菌二联活菌联合马来酸曲美布汀治疗，比较两组患者的临床治疗效果。结果：服药三天后，观察组的治疗总有效率为94.44%，明显高于对照组的81.48%，差异明显，具有统计学意义（P<0.05）。结论：利用酪酸杆菌双歧杆菌二联活菌联合马来酸曲美布汀对急性胃肠炎患者进行治疗，安全有效，能够改善患者的急性肠炎症状，值得在临床医学上的推广运用。“,”Objective To study the butyric acid bacteria bifid bacteria duplex living bacterium joint malefic acid trimebutine clinical effect for the treatment of acute gastroenteritis. Methods From 2012 to 2012 treated 108 cases of patients with acute gastroenteritis, and compare the clinical treatment effect of the experimental group and the control group patients.Results Treatment group total effective rate was 94.44%, significantly higher than the control group, 81.48% of the difference is obvious.ConclusionButyric acid bacteria bifid bacteria duplex living bacterium joint trimebutine malefic acid treatment of patients with acute gastroenteritis, safe and effective, is worth promoting.